Translational Development Acquisition Corp. financial data

Symbol
TDAC, TDACU, TDACW on Nasdaq
Location
52 E 83 Rd St., New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 15, 2025

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 0 shares
Entity Public Float 0 USD

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 347K USD
Operating Income (Loss) -347K USD
Nonoperating Income (Expense) 1.83M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 1.48M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 207K USD
Assets, Current 415K USD
Assets 177M USD
Accounts Payable, Current 16.2K USD +1193%
Liabilities, Current 323K USD
Liabilities 6.36M USD
Retained Earnings (Accumulated Deficit) -5.95M USD
Stockholders' Equity Attributable to Parent -5.94M USD -1071%
Liabilities and Equity 177M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -232K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 207K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares